Novavax (NVAX) Income from Continuing Operations (2010 - 2026)

Novavax's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 9491000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 101.83% year-over-year to 9491000.0; the TTM figure through Mar 2026 stood at 87835000.0 (down 118.35% YoY), while the FY2025 annual figure was 440302000.0, up 334.83% from the prior year.
• Income from Continuing Operations was 9491000.0 for Q1 2026 at Novavax, down from 17527000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 518646000.0 in Q1 2025 to a low of 510485000.0 in Q2 2022.
• Historically, Income from Continuing Operations has averaged 56452294.12 across 5 years, with a median of 121300000.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations slumped 244.49% in 2023, then soared 451.51% in 2025.
• A 5-year view of Income from Continuing Operations shows it stood at 182249000.0 in 2022, then rose by 2.12% to 178389000.0 in 2023, then jumped by 54.58% to 81030000.0 in 2024, then jumped by 121.63% to 17527000.0 in 2025, then plunged by 154.15% to 9491000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 9491000.0 (Q1 2026), 17527000.0 (Q4 2025), and 202379000.0 (Q3 2025), per Business Quant data.